Y010-1359 Screening compound: 3-[(3-bromo-4-methylphenyl)carbamoyl]-3-methyl-2-[(4-methylphenyl)methyl]propanoic acid

Y010-1359 Screening compound: 3-[(3-bromo-4-methylphenyl)carbamoyl]-3-methyl-2-[(4-methylphenyl)methyl]propanoic acid
Y010-1359 Screening compound: 3-[(3-bromo-4-methylphenyl)carbamoyl]-3-methyl-2-[(4-methylphenyl)methyl]propanoic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound Y010-1359
3-[(3-bromo-4-methylphenyl)carbamoyl]-3-methyl-2-[(4-methylphenyl)methyl]propanoic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y010-1359

Molecular Formula

C20H22BrNO3 (C20 H22 BrNO3)

Compound Name

3-[(3-bromo-4-methylphenyl)carbamoyl]-3-methyl-2-[(4-methylphenyl)methyl]propanoic acid

IUPAC name

3-[(3-bromo-4-methylphenyl)carbamoyl]-3-methyl-2-[(4-methylphenyl)methyl]propanoic acid

SMILES

CC(C(Cc1ccc(C)cc1)C(O)=O)C(Nc1cc(Br)c(C)cc1)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

404.3

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

4.466

Distribution Coefficient, logD

1.843

Water Solubility, LogSw

-4.20

Polar Surface Area

51.738

Acid Dissociation Constant (pKa)

4.78

Base Dissociation Constant (pKb)

0.66

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

30.00

Y010-1359 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
Targets:
  • Nuclear receptors
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with Y010-1359 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y010-1359?
Check Price and Availability of Y010-1359, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y010-1359 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y010-1359
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y010-1359
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y010-1359 available by request